You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 5, August 4, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (157)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Progress in Medical Defense Against Nerve Agents

COL Michael A. Dunn, MC; Frederick R. Sidell, MD

JAMA. 1989;262(5):649-652.


Abstract

For nearly 50 years, nerve agents have constituted a serious threat that has stimulated extensive efforts to develop effective medical countermeasures. Recent progress in producing pharmacologic defenses suggests that humans can be largely protected from the lethal and prolonged incapacitating effects of these compounds on a chemical battlefield. Current research on new approaches to binding and inactivating nerve agents may further decrease their potential as a threat against protected persons.

(JAMA. 1989;262:649-652)



Author Affiliations

USA

From the US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Md.


Footnotes

Reprint requests to Commander, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5425 (COL Dunn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsants for Nerve Agent-Induced Seizures: The Influence of the Therapeutic Dose of Atropine
Shih et al.
J. Pharmacol. Exp. Ther. 2007;320:154-161.
ABSTRACT | FULL TEXT  

Overcoming inhibitions
Kellar
Proc. Natl. Acad. Sci. USA 2006;103:13263-13264.
FULL TEXT  

The Pediatrician and Disaster Preparedness
Markenson et al.
Pediatrics 2006;117:e340-e362.
ABSTRACT | FULL TEXT  

Pathophysiological and clinical aspects of combat anticholinesterase poisoning
Weinbroum
Br Med Bull 2005;72:119-133.
ABSTRACT | FULL TEXT  

Nerve Agents: A Comprehensive Review
Wiener and Hoffman
J Intensive Care Med 2004;19:22-37.
ABSTRACT  

Anticholinergic and Antiglutamatergic Agents Protect against Soman-Induced Brain Damage and Cognitive Dysfunction
Raveh et al.
Toxicol Sci 2003;75:108-116.
ABSTRACT | FULL TEXT  

Neurological Aspects of Biological and Chemical Terrorism: A Review for Neurologists
Martin and Adams
Arch Neurol 2003;60:21-25.
ABSTRACT | FULL TEXT  

Analytic Reviews: Management of Patients Exposed to Biological and Chemical Warfare Agents
Marik and Bowles
J Intensive Care Med 2002;17:147-161.
ABSTRACT  

The Role of the Clinical Laboratory in Managing Chemical or Biological Terrorism
Jortani et al.
Clin. Chem. 2000;46:1883-1893.
ABSTRACT | FULL TEXT  

Chemical-Biological Terrorism and Its Impact on Children: A Subject Review
Committee on Environmental Health and Committee on
Pediatrics 2000;105:662-670.
ABSTRACT | FULL TEXT  

Self-reported Exposure to Neurotoxic Chemical Combinations in the Gulf War: A Cross-sectional Epidemiologic Study
Haley and Kurt
JAMA 1997;277:231-237.
ABSTRACT  

Blood Purification for Severe Sarin Poisoning After the Tokyo Subway Attack
Yokoyama et al.
JAMA 1995;274:379-379.
ABSTRACT  

Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning
Worek et al.
Hum Exp Toxicol 1995;14:634-642.
ABSTRACT  

Unexplained Illnesses Among Desert Storm Veterans: A Search for Causes, Treatment, and Cooperation
Persian Gulf Veterans Coordinating Board et al.
Arch Intern Med 1995;155:262-268.
ABSTRACT  

Behavioural Toxicity of Anticholinesterases in Humans and Animals - A Review
D'Mello
Hum Exp Toxicol 1993;12:3-7.
ABSTRACT  

Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions
Keeler et al.
JAMA 1991;266:693-695.
ABSTRACT  

Disposing of the US Chemical Weapons Stockpile: An Approaching Reality
Carnes and Watson
JAMA 1989;262:653-659.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.